Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial - Homma_2016_J.Alzheimers.Dis_52_345 |
Author(s) : Homma A , Atarashi H , Kubota N , Nakai K , Takase T |
Ref : J Alzheimers Dis , 52 :345 , 2016 |
Abstract : Homma_2016_J.Alzheimers.Dis_52_345 |
ESTHER : Homma_2016_J.Alzheimers.Dis_52_345 |
PubMedSearch : Homma_2016_J.Alzheimers.Dis_52_345 |
PubMedID: 26967222 |
Title : Alzheimer's disease with cerebrovascular disease: current status in the Asia-Pacific region - Chen_2016_J.Intern.Med_280_359 |
Author(s) : Chen C , Homma A , Mok VC , Krishnamoorthy E , Alladi S , Meguro K , Abe K , Dominguez J , Marasigan S , Kandiah N , Kim SY , Lee DY , De Silva HA , Yang YH , Pai MC , Senanarong V , Dash A |
Ref : J Intern Med , 280 :359 , 2016 |
Abstract : Chen_2016_J.Intern.Med_280_359 |
ESTHER : Chen_2016_J.Intern.Med_280_359 |
PubMedSearch : Chen_2016_J.Intern.Med_280_359 |
PubMedID: 26992016 |
Title : A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease - Nakamura_2015_Dement.Geriatr.Cogn.Dis.Extra_5_361 |
Author(s) : Nakamura Y , Strohmaier C , Tamura K , Kataoka N , Nakano M , Oda S , Nishimura K , Homma A |
Ref : Dement Geriatr Cogn Dis Extra , 5 :361 , 2015 |
Abstract : Nakamura_2015_Dement.Geriatr.Cogn.Dis.Extra_5_361 |
ESTHER : Nakamura_2015_Dement.Geriatr.Cogn.Dis.Extra_5_361 |
PubMedSearch : Nakamura_2015_Dement.Geriatr.Cogn.Dis.Extra_5_361 |
PubMedID: 26557135 |
Title : Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials - Winblad_2009_Curr.Med.Res.Opin_25_2577 |
Author(s) : Winblad B , Black SE , Homma A , Schwam EM , Moline M , Xu Y , Perdomo CA , Swartz J , Albert K |
Ref : Curr Med Res Opin , 25 :2577 , 2009 |
Abstract : Winblad_2009_Curr.Med.Res.Opin_25_2577 |
ESTHER : Winblad_2009_Curr.Med.Res.Opin_25_2577 |
PubMedSearch : Winblad_2009_Curr.Med.Res.Opin_25_2577 |
PubMedID: 19735164 |
Title : Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles - Shigeta_2001_CNS.Drug.Rev_7_353 |
Author(s) : Shigeta M , Homma A |
Ref : CNS Drug Rev , 7 :353 , 2001 |
Abstract : Shigeta_2001_CNS.Drug.Rev_7_353 |
ESTHER : Shigeta_2001_CNS.Drug.Rev_7_353 |
PubMedSearch : Shigeta_2001_CNS.Drug.Rev_7_353 |
PubMedID: 11830754 |
Title : Current status of clinical trials for Alzheimer-type dementia in Japan: strategies to facilitate the development of antidementia drugs - Homma_2000_Alzheimer.Dis.Assoc.Disord_14 Suppl 1_S123 |
Author(s) : Homma A |
Ref : Alzheimer Disease & Associated Disorders , 14 Suppl 1 :S123 , 2000 |
Abstract : Homma_2000_Alzheimer.Dis.Assoc.Disord_14 Suppl 1_S123 |
ESTHER : Homma_2000_Alzheimer.Dis.Assoc.Disord_14 Suppl 1_S123 |
PubMedSearch : Homma_2000_Alzheimer.Dis.Assoc.Disord_14 Suppl 1_S123 |
PubMedID: 10850741 |
Title : Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group - Homma_2000_Dement.Geriatr.Cogn.Disord_11_299 |
Author(s) : Homma A , Takeda M , Imai Y , Udaka F , Hasegawa K , Kameyama M , Nishimura T |
Ref : Dementia & Geriatric Cognitive Disorders , 11 :299 , 2000 |
Abstract : Homma_2000_Dement.Geriatr.Cogn.Disord_11_299 |
ESTHER : Homma_2000_Dement.Geriatr.Cogn.Disord_11_299 |
PubMedSearch : Homma_2000_Dement.Geriatr.Cogn.Disord_11_299 |
PubMedID: 11044775 |
Title : Placebos in clinical trials in Alzheimer disease: an international discussion - |
Author(s) : Whitehouse PJ , Arizaga R , Brodaty H , Gauthier S , Graham N , Green RC , Homma A , Mangone C , Senanarong V , Xu XH |
Ref : Alzheimer Disease & Associated Disorders , 13 :121 , 1999 |
PubMedID: 10485568 |